PIGO and hyperinsulinemic hypoglycemia, familial, 4: In this study, we report the development of effective adeno-associated virus (AAV)-mediated gene therapy using a mouse model of inherited GPI deficiency caused by phosphatidylinositol glycan anchor biosynthesis class O (PIGO) mutations, with the aim of developing gene therapy applicable to human patients.